Back to Trials
NCT07120763PHASE3Recruiting

Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures

State University of New York at Buffalo

Start Date

8/22/2025

Completion Date

8/22/2027

Summary

The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric patients presenting with distal radius fractures requiring reduction, compared to control of standard full conscious sedation using ketamine.

Eligibility Criteria

Age Range: 3 years to 17 years

Inclusion Criteria: * Children requiring reduction for distal radius fracture * Children presenting to the emergency department * Children who are ages 3 to 17 years. Exclusion Criteria: * Pediatric patients \<3 years old * Adult patients (i.e. ages 18 or up) * Pediatric patients with injury patterns that are not amenable to hematoma block. * Children who are not a candidate for sedation related to BMI \> 95%tile for age, ASA class \> 2, Mallampati score \> 2, and pregnant patients

Interventions

DRUG

Ketamine + Lidocaine

DRUG

Ketamine group

DRUG

Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Distal Radius Fracture ReductionPain ControlPediatric Fractures

Locations

Oshei Children's Hospital

Buffalo, New York 14203

United States